MiMedx Group (MDXG)
(Real Time Quote from BATS)
$6.43 USD
-0.12 (-1.83%)
Updated Aug 20, 2024 12:48 PM ET
4-Sell of 5 4
C Value A Growth B Momentum A VGM
Industry / Sector Report
Industry : Medical - Biomedical and Genetics
Zacks Industry Rank
Top 28% (70 out of 251)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.36 | 9.99 |
Current Quarter Estimate | 0.08 | 3.27 | 61.00 |
Year Ago Quarter Estimate | 0.05 | -4.89 | 54.84 |
Next Quarter Estimate | 0.08 | 4.49 | 63.00 |
Next Year Estimate | 0.47 | 25.31 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 190.00 | 18.30 | 15.67 |
Next Year | 62.07 | 9.00 | 11.34 |
Last 5 Years | NA | 0.90 | 8.10 |
Next 5 Years | NA | 21.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 27.29 | -8.79 |
Price/Book (MRQ) | 5.72 | 2.01 |
Price/Cash Flow (MRFY) | 34.83 | 14.95 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | 23.63% | -140.17% |
Return on Equity (TTM) | 34.24% | -58.18% |
Debt to Equity (MRQ) | 0.11 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.